Inhibrx Biosciences, Inc.

INBX

Inhibrx Biosciences, Inc.

INBX

Insider Sentiment (TTM):

Last Purchase:2024-11-20Last Sale:2025-10-07Shares Purchased (TTM):0Shares Sold (TTM):350,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:12,687,921Shares Outstanding:15,585,000Institutional Ownership Pct.:81.41%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Nonrelated Party	-	-	0	-0	0	0	0	0	0
Related Party	-	-	0	-0	0	0	0	0	0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	133	162	124	153	187	217	153	196	227
Other Receivables Net Current	0	0	0	1	1	-	0	-	1
Prepaid Expense And Other Assets Current	9	9	8	7	6	7	7	10	14
Assets Current	142	171	133	161	194	223	160	207	242
Property Plant And Equipment Net	3	3	4	4	5	6	6	7	8
Operating Lease Right Of Use Asset	5	5	6	6	6	7	7	2	2
Other Assets Noncurrent	5	4	4	6	7	7	7	7	7
Assets	154	184	146	177	212	243	181	223	258
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	10	9	6	7	8	9	9	12	13
Accrued Liabilities Current	16	15	26	27	28	33	30	30	24
Operating Lease Liability Current	2	2	2	2	2	2	2	2	2
Liabilities Current	28	27	34	36	39	44	41	44	39
Long Term Debt Noncurrent	176	175	101	100	99	99	0	0	0
Operating Lease Liability Noncurrent	3	3	4	5	5	6	6	0	0
Liabilities	207	205	138	141	144	148	47	44	39
Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	263	259	254	250	247	244	240	237	234
Retained Earnings Accumulated Deficit	-316	-280	-246	-213	-178	-149	-106	-58	-14
Stockholders Equity	-53	-21	8	37	69	94	134	178	219
Liabilities And Stockholders Equity	154	184	146	177	212	243	181	223	258
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	15	15	15	15	15	15	15	15	15
Preferred Stock Shares Issued	0	0	-	0	0	0	-	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	15	15	15	14	14	14	14	14	13
Shares Outstanding	15	15	15	14	14	14	14	14	14

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-25.09%	-16.00%	-27.06%	-	-	-	-	-	-	-	-	-
2025	28.41%	50.65%	99.26%	19.56%	51.25%	246.46%	13.07%	-5.17%	-3.61%	16.03%	107.11%	34.13%
2024	-	-	-	33.27%	30.62%	39.82%	9.56%	12.70%	-5.23%	-16.71%	-19.84%	-0.14%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Liquidity Ratios
Current Ratio	5.07	6.46	3.93	4.49	4.98	5.12	3.94	4.70	6.20
Quick Ratio	4.76	6.10	3.68	4.28	4.82	4.97	3.76	4.48	5.84
Working Capital	114.15M	144.83M	99.03M	125.44M	155.03M	179.75M	119.67M	163.35M	203.01M
Leverage & Debt
Debt to Equity	-3.91	-9.75	17.33	3.82	2.09	1.57	0.35	0.25	0.18
Interest Coverage TTM	-8.21	-9.45	-11.07	-13.29	-17.25	-23.14	-	-	-
Debt Ratio	1.34	1.11	0.95	0.79	0.68	0.61	0.26	0.20	0.15
Efficiency & Turnover
Asset Turnover TTM	0.00	0.01	0.01	0.01	0.01	0.00	-	-	-
Per Share Metrics
Diluted EPS TTM	-8.82	-8.35	-9.04	-15.11	-15.67	106.30	-	-	-
Free Cash Flow Per Share TTM	-8.28	-8.47	-8.39	-6.95	-6.74	-15.06	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-
Margin Metrics
Operating Profit Margin TTM	-	-9,465.46%	-10,386.54%	-16,275.36%	-17,202.86%	-187,174.50%	-	-	-
Net Profit Margin TTM	-	-10,014.23%	-10,773.46%	-16,699.71%	-17,314.57%	822,130.50%	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-100.00%	550.00%	-	-	-	-	-	-	-
Net Income Growth (1Y)	-43.00%	-107.92%	-	-	-	-	-	-	-
EPS Growth (1Y)	-43.73%	-107.86%	-	-	-	-	-	-	-
Valuation Metrics
P/E TTM	-10.74	-8.05	-8.74	-2.23	-0.91	0.13	-	-	-
P/B TTM	-28.02	-49.81	153.07	14.15	3.22	2.29	1.71	1.36	0.94
P/S TTM	-	805.98	941.13	372.36	157.66	1,081.99	-	-	-
Market Cap	1.48B	1.05B	1.22B	521.30M	220.73M	216.40M	227.95M	242.23M	207.15M
Enterprise Value	1.53B	1.06B	1.20B	468.13M	133.44M	98.53M	75.35M	45.90M	-19.71M
Calculated Values
Free Cash Flow TTM	-129.79M	-131.98M	-129.87M	-107.57M	-104.26M	-232.92M	-	-	-
Net Debt	42.94M	13.34M	-23.66M	-53.17M	-87.29M	-117.87M	-152.60M	-196.33M	-226.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-10-07Sale

Owner: Viking, Global Opportunit…

Title: -

Shares: 350,000

Price/Share: $32.25

Value: $11,287,500.00

Shares Owned: 67,018

Relationship: TenPercentOwner

Ownership: Indirect

2024-11-20Purchase

Owner: Kayyem, Jon Faiz

Title: -

Shares: 37,500

Price/Share: $14.19

Value: $532,125.00

Shares Owned: 69,843

Relationship: Director

Ownership: Indirect

2024-10-03Purchase

Owner: Vuori, Kristiina Md

Title: -

Shares: 6,667

Price/Share: $15.00

Value: $100,005.00

Shares Owned: 20,443

Relationship: Director

Ownership: Direct

2024-09-16Purchase

Owner: Lappe, Mark

Title: Chief Executive Officer

Shares: 13,037

Price/Share: $17.13

Value: $223,323.81

Shares Owned: 705,548

Relationship: Director,Officer

Ownership: Indirect

2024-09-11Purchase

Owner: Vuori, Kristiina Md

Title: -

Shares: 6,457

Price/Share: $15.07

Value: $97,306.99

Shares Owned: 13,776

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-10-07	Viking, Global Opportunit…	TenPercentOwner	-	Indirect	Sale	350,000	32.25	$11,287,500.00	67,018	4
2024-11-20	Kayyem, Jon Faiz	Director	-	Indirect	Purchase	37,500	14.19	$532,125.00	69,843	4
2024-10-03	Vuori, Kristiina Md	Director	-	Direct	Purchase	6,667	15.00	$100,005.00	20,443	4
2024-09-16	Lappe, Mark	Director,Officer	Chief Executive Officer	Indirect	Purchase	13,037	17.13	$223,323.81	705,548	4
2024-09-11	Vuori, Kristiina Md	Director	-	Direct	Purchase	6,457	15.07	$97,306.99	13,776	4
2024-09-10	Lappe, Mark	Director,Officer	Chief Executive Officer	Indirect	Purchase	8,500	15.19	$129,115.00	665,548	4
2024-09-03	Lappe, Mark	Director,Officer	Chief Executive Officer	Indirect	Purchase	20,000	15.98	$319,600.00	165,000	4
2024-08-29	Vuori, Kristiina Md	Director	-	Direct	Purchase	7,140	14.00	$99,960.00	7,140	4
2024-08-28	Manhard, Kimberly	Director	-	Indirect	Purchase	10,000	13.98	$139,800.00	10,000	4
2024-08-23	Forsyth, Douglas	Director	-	Indirect	Purchase	59,812	14.07	$841,554.84	224,564	4
2024-08-21	Lappe, Mark	Director,Officer	Chief Executive Officer	Indirect	Purchase	12,945	12.93	$167,378.85	54,865	4
2024-06-05	Kayyem, Jon Faiz	Director	-	Indirect	Purchase	57,549	17.56	$1,010,560.44	1,150,410	4
2024-06-04	Kayyem, Jon Faiz	Director	-	Indirect	Purchase	89,063	17.84	$1,588,883.92	1,092,861	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

81.41%

Inst. Shares: 12,687,921

Shares Outstanding: 15,585,000

2025-12-31

82.13%

Inst. Shares: 12,719,285

Shares Outstanding: 15,487,000

2025-09-30

67.63%

Inst. Shares: 10,468,157

Shares Outstanding: 15,478,000

2025-06-30

66.43%

Inst. Shares: 10,276,088

Shares Outstanding: 15,468,000

2025-03-31

68.63%

Inst. Shares: 10,616,181

Shares Outstanding: 15,468,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	12,687,921	15,585,000	81.41%
2025-12-31	12,719,285	15,487,000	82.13%
2025-09-30	10,468,157	15,478,000	67.63%
2025-06-30	10,276,088	15,468,000	66.43%
2025-03-31	10,616,181	15,468,000	68.63%
2024-12-31	10,882,767	14,802,000	73.52%
2024-09-30	8,777,521	15,468,000	56.75%
2024-06-30	9,584,933	14,619,000	65.56%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Inhibrx Biosciences, Inc. (INBX) — SEC Financial Statements & Analysis

Inhibrx Biosciences, Inc. (INBX) is a biological products, (no diagnostic substances) company, incorporated in DE. Inhibrx Biosciences, Inc. trades on Nasdaq as: INBX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Inhibrx Biosciences, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -3.91x, a Price-to-Sales (P/S) ratio of 805.98x (TTM), a Price-to-Book (P/B) ratio of -28.02x (TTM), at a market cap of $1.48B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: -3.91x
P/S TTM: 805.98x
P/B TTM: -28.02x
Market Cap: $1.48B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Inhibrx Biosciences, Inc. in?

Inhibrx Biosciences, Inc. (INBX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is INBX's market cap?

Inhibrx Biosciences, Inc. (INBX) has a market capitalization of $1.48B as of 2026-06-30.

What exchange does INBX trade on?

Inhibrx Biosciences, Inc. (INBX) trades on the Nasdaq.

Where is Inhibrx Biosciences, Inc. incorporated?

Inhibrx Biosciences, Inc. is incorporated in DE.